Effect of Cuprofilin on Experimental Atherosclerosis

Overview

Journal Biol Trace Elem Res

Date 1995 Apr 1

PMID 7626376

Citations 2

Authors

M Vlad

E BORDAS

E Caseanu

G UZA

E Creteanu

C Polinicenco

Affiliations

Soon will be listed here.

Abstract

The effect of Cuprofilin, a newly synthesized C.(II)-chlorophyll complex, was assessed in rats with experimental atherosclerosis. The study was focused on changes in serum cholesterol, lipids, and triglycerides concentration as well as on serum and abdominal aorta Cu and Zn values. It has been ascertained that after 90 d in animals fed a rich lipid diet there was a statistically significant increase in serum cholesterol, triglycerides, and lipid concentration (p < 0.01). A significant augmentation of serum Cu values (p < 0.01) accompanied by a marked lowering of the same element in abdominal aorta (p < 0.01) was also found, as compared to the results registered in the control group. However, Cuprofilin, administered for 90 d in the group of animals with experimental atherosclerosis, significantly decreased the serum cholesterol, triglycerides, and serum lipid values (p < 0.01), increased copper content in aortic tissue (p < 0.01) and lowered serum copper concentration (p < 0.01) as compared to the untreated group. Moreover, in the aorta of administered animals the lipid infiltration has been demonstrated to be significantly diminished vs the untreated group.

Citing Articles

L-Carnitine effect on induced hyperlipidemia on premature rats: fertility profile.

Karam K, Alebady A, Gazar Chelab Al-Nailey K, Al-Delemi D J Med Life. 2022; 15(1):124-131.

PMID: 35186146 PMC: 8852634. DOI: 10.25122/jml-2021-0213.

Chronic hypertension increases aortic endothelial hydraulic conductivity by upregulating endothelial aquaporin-1 expression.

Toussaint J, Raval C, Nguyen T, Fadaifard H, Joshi S, Wolberg G Am J Physiol Heart Circ Physiol. 2017; 313(5):H1063-H1073.

PMID: 28733452 PMC: 5792199. DOI: 10.1152/ajpheart.00651.2016.

References

Sorenson J, HANGARTER W . Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate. Inflammation. 1977; 2(3):217-38. DOI: 10.1007/BF00917597. View

Carr T, Lei K . High-density lipoprotein cholesteryl ester and protein catabolism in hypercholesterolemic rats induced by copper deficiency. Metabolism. 1990; 39(5):518-24. DOI: 10.1016/0026-0495(90)90011-z. View

Klevay L . Dietary copper: a powerful determinant of cholesterolemia. Med Hypotheses. 1987; 24(2):111-9. DOI: 10.1016/0306-9877(87)90093-4. View

Allen K, Klevay L . Cholesterolemia and cardiovascular abnormalities in rats caused by copper deficiency. Atherosclerosis. 1978; 29(1):81-93. DOI: 10.1016/0021-9150(78)90096-5. View

Klevay L, Inman L, Johnson L, Lawler M, Mahalko J, Milne D . Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism. 1984; 33(12):1112-8. DOI: 10.1016/0026-0495(84)90096-9. View

Klevay L . Coronary heart disease: the zinc/copper hypothesis. Am J Clin Nutr. 1975; 28(7):764-74. DOI: 10.1093/ajcn/28.7.764. View

Saari J . Dietary copper deficiency and endothelium-dependent relaxation of rat aorta. Proc Soc Exp Biol Med. 1992; 200(1):19-24. DOI: 10.3181/00379727-200-43388. View

Hunsaker H, Morita M, Allen K . Marginal copper deficiency in rats. Aortal morphology of elastin and cholesterol values in first-generation adult males. Atherosclerosis. 1984; 51(1):1-19. DOI: 10.1016/0021-9150(84)90140-0. View

Vlad M, BORDAS E, Tomus R, Sava D, Farkas E, UZA G . Effect of copper sulfate on experimental atherosclerosis. Biol Trace Elem Res. 1993; 38(1):47-54. DOI: 10.1007/BF02783981. View

10.

Roberts D, Huff M, Carroll K . Plasma lipoprotein changes in suckling and weanling rabbits fed semipurified diets. Lipids. 1979; 14(6):566-71. DOI: 10.1007/BF02533533. View

11.

Jaudon M, Clavel J, Delattre J, Galli A . [Serum zinc and copper in hypercholesterolemia]. Pathol Biol (Paris). 1987; 35(4):387-90. View

12.

Cucuianu M, POPESCU T, OPINCARU A, HARAGUS S . Serum pseudocholinesterase and ceruloplasmin in various types of hyperlipoproteinemia. Clin Chim Acta. 1975; 59(1):19-27. DOI: 10.1016/0009-8981(75)90213-2. View

13.

Klevay L . Interactions of copper and zinc in cardiovascular disease. Ann N Y Acad Sci. 1980; 355:140-51. DOI: 10.1111/j.1749-6632.1980.tb21334.x. View

14.

Klevay L . Copper and ischemic heart disease. Biol Trace Elem Res. 2013; 5(4-5):245-55. DOI: 10.1007/BF02987211. View

15.

Weber C . Copper response to rheumatoid arthritis. Med Hypotheses. 1984; 15(4):333-48. DOI: 10.1016/0306-9877(84)90150-6. View

16.

Truswell A . Diet and plasma lipids--a reappraisal. Am J Clin Nutr. 1978; 31(6):977-89. DOI: 10.1093/ajcn/31.6.977. View

17.

Okuyama S, Hashimoto S, Aihara H, Willingham W, Sorenson J . Copper complexes of non-steroidal antiinflammatory agents: analgesic activity and possible opioid receptor activation. Agents Actions. 1987; 21(1-2):130-44. DOI: 10.1007/BF01974933. View

18.

Sorenson J . Copper chelates as possible active forms of the antiarthritic agents. J Med Chem. 1976; 19(1):135-48. DOI: 10.1021/jm00223a024. View

19.

Klevay L . Hypercholesterolemia in rats produced by an increase in the ratio of zinc to copper ingested. Am J Clin Nutr. 1973; 26(10):1060-8. DOI: 10.1093/ajcn/26.10.1060. View